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A B S T R A C T
BACKGROUND: Percutaneous transluminal angioplasty (PTA) for significant steno-
sis involving the origin of the vertebral artery is now a well established treatment 
for selected patients when posterior cerebral arterial circulation is compromised. We 
demonstrate from our short and long-term results, after transluminal treatment of 
subclavian and vertebral artery stenosis, the feasibility and safety of treatment with 
balloon angioplasty and stenting.
PATIENTS AND METHODS: A total of 181 patients underwent endovascular treatment 
and were divided into two groups. In group A, we treated patients with chronic verte-
brobasilar insufficient. In this group, 21 patients with severe vertebral artery stenosis 
had also concomitant severe stenosis in other supra aortic arteries. In group B we 
treated patients with subclavian steal syndrome. In this group 21 patients presented 
with coexistence of severe stenosis in other supra aortic arteries. Stent patency of sub-
clavian and vertebral artery during follow up was assessed by duplex scan and physical 
examination, with comparison of brachial blood pressure of both arms especially in 
patients with subclavian stenosis. Digital angiography was performed in available pa-
tients. Cerebral oximetry and intracranial Doppler were used to determine the group 
of patients that we had to treat with balloon angioplasty and stenting.
RESULTS: Successful stenting was achieved in all cases. There were no complications. 
The primary stenting patency during follow-up (mean 8.6 months) was 98.6%. With 
use of intracranial Doppler we found 31 patients with higher blood flow in the basilar 
artery after stenting and 24 patients were found with increased brain regional oxygen 
saturation in the anterior cerebral artery.
CONCLUSION: Endovascular treatment of subclavian and vertebral arteries with bal-
loon angioplasty and stenting was found to be necessary in certain cases and a less 
invasive alternative to surgical repair. Long-term results must still be confirmed in 
further studies.
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I N T R O D U C T I O N
The back of the brain contains structures which are cru-
cial for sustaining life. For instance, the brainstem controls 
respiration, swallowing, and the level of consciousness. Other 
structures of the back of the brain are the occipital lobes (the 
vision areas of the brain) and the cerebellum (which controls 
motor coordination). Obstructive lesions of the vertebral ar-
teries may cause symptoms of vertebrobasilar insufficiency. 
When there is severe stenosis or occlusion in the subclavian 
artery, the phenomenon of subclavian steal syndrome occurs, 
which usually causes also symptoms from the vertebrobasilar 
territory because blood supply to the arm is provided by the 
ipsilateral vertebral artery. Although these are often ignored, 
symptomatic atherosclerotic stenoses involving this circulation 
will often respond to balloon angioplasty or primary stenting 
with real potential benefits to the patient in terms of symptom 
resolution.
We herein present our single-center experience with bal-
loon angioplasty and stenting of the subclavian and vertebral 
arteries, evaluating simultaneously the brain regional oxygen 
saturation (rSO2) changes during the vertebral artery occlu-
sion period. We also studied the basilar artery runoff changes 
before and after vertebral and subclavian artery angioplasty, to 
further evaluate the efficacy of the procedure and to identify 
patients in whom subclavian and vertebral artery angioplasty 
should be applied.
PA T I E N T S  A N D  M E T H O D S
From September 2000 to February 2004, 181 patients (159 
men and 22 women; mean age 63.8 years) underwent angi-
oplasty and stenting of the subclavian and vertebral arteries. 
These patients were divided in to two groups. In group A, we 
studied 52 patients with chronic vertebrobasilar insufficient 
suffering from severe vertebral artery stenosis. Eleven of these 
patients presented with coexistence of ipsilateral severe inter-
nal carotid artery stenosis, with contralateral (6 patients) and 
bilateral internal carotid artery stenosis (4 patients). Eleven 
patients in group A presented with hypoplastic contralateral 
vertebral artery. In group B, we studied 129 patients with 
symptomatic severe subclavian artery stenosis. Twelve of these 
patients had also bilateral internal carotid artery stenosis, 
while 6 patients had contralateral internal carotid stenosis 
and 3 patients had ipsilateral carotid stenosis.
All patients underwent pre-interventional neurological 
evaluation, Duplex scan, and brain computed tomography 
(CT) scan. Aortic arch angiography and four-vessel digital 
angiography were performed to evaluate extra- and intra-cra-
nial arteries. Special attention was paid to the subclavian and 
vertebral arteries and to the collateral blood flow to posterior 
cerebral circulation.
Vertebral artery stenosis was considered to be angiographi-
cally significant when greater than 70%. The angiographic ap-
pearance of the atherosclerotic vertebral lesions in this series 
was uniform, showing smooth luminal stenosis without plaque 
ulceration at the origin of the vessel. There was no evidence 
of distal vertebral or basilar artery stenosis in any patient. 
Endovascular approach was performed via a transfemoral 
route with use of local anesthesia. After arterial puncture, 
a 7F sheath was inserted and systemic anticoagulation was 
achieved with heparin (5000 IU). A 7F guiding catheter was 
then navigated into the subclavian artery. The narrowed arte-
rial segment was then crossed with a 160-cm-long 0.014-inch 
guidewire that was navigated into the normal distal cervical 
vertebral artery. The PTA balloon catheter with the stent, 
was then placed over the guidewire and directed across the 
lesion site. The balloon was inflated up to the maximum 
recommended pressure to deploy and impact the stent into 
the inner arterial wall. Balloon inflation never lasted longer 
than 20 seconds.
The vertebral arteries in our patients had diameters of 4 
to 5 mm. In all cases we used coronary stents from Boston 
Scientific Corp. In both groups during the procedure there was 
continuous monitoring of blood pressure, ECG and oxygen 
saturation. A 3100 SD Soma sensor was placed in the patients 
frontopariental region, left and right and then it was connected 
with a cerebral oximeter 3100 INVOS R. For both groups 
the rSO2 levels were recorded: a) Before femoral puncture 
and sheath insertion b) during guide catheter insertion in the 
vertebral artery origin and c) during balloon inflation and/or 
stent placement (occlusion period) (Table 1).
Immediately after stent placement, angiography was per-
formed to assess the treated vessel. Careful attention was also 
paid to the intracranial circulation to exclude any sign of distal 
embolization. Patients were discharged from the hospital 24 
hours after the procedure. They received 75 mg of ticlopidine 
and aspirin 100 mg daily for at least one year after stenting. 
Stent patency of subclavian and vertebral arteries during 
follow up was assessed by duplex scan and physical examina-
tion; particluarly in the patients with subclavian stenosis, this 
was also done with comparison of brachial blood pressure on 
both arms in all patients. Digital angiography was performed 
in available patients.
All patients of group A (43 male and 8 female patients) 
underwent vertebral angioplasty and stenting using balloon-
expandable coronary stents (Fig. 1). All lesions were located 
at the origin of the vertebral artery (10 right, 42 left). Our 
population had a wide variety of symptoms of posterior fossa 
and posterior cerebral ischemia. Symptoms were refractory 
to medical therapy, including antiplatelet and anticoagulant 
medication, in all patients. Table 2 summarizes the patients’ 
clinical data.
In group B, we treated 129 symptomatic patients with 
severe subclavian artery stenosis (Fig. 2). 12 of these patients 
had also bilateral internal carotid artery stenosis, with con-
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tralateral internal carotid stenosis in 6 patients and ipsilateral 
internal carotid stenosis in 3 patients (Table 3).
R E S U L T S
Successful stenting was achieved in all cases (subclavian 
& vertebral arteries). There were no complications. The pri-
mary stenting patency during follow-up (mean 8.6 months) 
was 98.6%. A total of 31 patients presented with post stent-
ing increased blood flow in the basilar artery and 24 patients 
TABLE 1
TABLE 2. Group A
No of Cases Referring symptoms Angiographic findings
5 patients History of drop-attacks, vertigo Severe stenosis of the left VA in 5 patients & 3 of these patients with 
severe LICA stenosis 
11 patients History of vertigo, nausea & dizziness Severe stenosis of the left VA origin in 8 patients & of the right VA in 3 
patients; 6 pts with severe LICA stenosis 
34 patients History of dizziness, vertigo Severe stenosis of the left VA origin in 27 patients & right VA in 7 
patients. 2 patients with bilateral severe stenosis, 2 patients with severe 
LICA stenosis & 6 patients with contralateral stenosis
2 patients Several episodes of drop-attacks followed 
by right hemiparesis, left arm paresis, right 
facial numbness & dysarthria
Severe stenosis of the left VA origin & bilateral severe internal carotid 
artery stenosis in all pts.
VA = vertebral artery; LICA = left internal carotid artery
FIGURE 1. Vertebral angioplasty and stenting in a 66-year-old 
symptomatic patient (Catheterization & Interventional Lab, 
General Hospital of Nikaea, Piraeus).
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were found with increased brain rSO2 in the anterior cerebral 
artery.
Symptoms resolved in all patients after endovascular 
treatment. In no case was the residual stenosis greater than 
20% nor were there any signs of distal embolization on the 
immediate control angiograms. No transient or permanent 
neurological deficits occurred.
D I S C U S S I O N
The coexistence of supra-aortic atherosclerotic vascular 
disease is related to high incidence of myocardial infarction, 
stroke and mortality. Study and endovascular treatment of this 
disease is a great challenge for the cardiologist. Endovascular 
management of supra-aortic atherosclerotic vascular disease 
is becoming relatively common in the innominate, subclavian, 
and carotid arteries. However, revascularization of vertebral 
artery disease is an infrequently used treatment option due 
to several reasons: 1) stroke etiology and prevention generally 
considered with respect to carotid disease as posterior circu-
lation ischemia is poorly defined; 2) the limited success and 
excessive morbidity have made surgery an unattractive option 
for vertebral artery revascularization; 3) routine screening for 
posterior circulation disease as an etiology for stroke is rarely 
performed; and 4) endovascular treatment of vertebrobasilar 
insufficiency is not routinely performed in peripheral inter-
ventional programs.
Randomized data comparing medical therapy, endovas-
cular treatment, or surgical treatment do not exist.1,2 Also we 
know that the majority of patients with symptoms of posterior 
cerebral circulation ischemia can be managed with conserva-
tive treatment, including anticoagulation and antiplatelet 
medication.³ Most patients tolerate occlusion of one vertebral 
artery because there is usually sufficient blood perfusion from 
the contralateral side. For patients presenting with bilateral 
vertebral stenosis who are refractory to medical treatment, 
PTA is a viable alternative to surgery. Stents are used in order 
to improve blood flow to the posterior cerebral circulation and 
to reduce the risk of distal embolization.4
Ultrasound is the most common test for diagnosis of 
ischemia in the posterior circulation (vertebrobasilar insuf-
ficiency). MRI angiography (MRA) or DC angiogram are very 
useful to estimate the whole supra-aortic and brain arterial 
branch situation. CT scan and an electrocardiogram (ECG) 
and/or Holter monitoring to look for arrhytmias are also 
necessary before taking any therapeutic action.
Prognosis depends in part on the underlying cause. Strokes 
of the brainstem region are potentially life-threatening and 
demand urgent medical care. The most important prognos-
tic factors are age and associated medical problems. When 
patients are young and have no significant medical problems, 
a substantial recovery can be expected. Recovery also de-
pends upon the area of the brain that has been affected. The 
prognosis is very poor when the patient is in coma or cannot 
move both arms and legs. The complications of stroke are 
respiratory failure (which may require use of mechanical 
respiration), lung problems (especially respiratory infections), 
myocardial infarction, dehydration and swallowing problems. 
Problems with movement and/or sensation include paralysis, 
and numbness and the formation of clots in the legs. Prevention 
of vertebrobasilar insufficiency includes cessation of smoking, 
regular exercise, blood pressure control, healthy diet (low 
cholesterol diet), and management of diabetes. Prevention 
of dissection includes avoidance of neck manipulation and 
TABLE 3. Group B
No of Cases Referring symptoms Angiographic findings
72 patients History of left arm claudication, 
dizziness & vertigo.
Severe stenosis of the left SA in 69 patients & of the right SA in 3 patients. 
Bilateral severe ICA stenosis in 10 patients, contralateral ICA stenosis in3 patients 
& ipsilateral ICA stenosis in 3 patients 
39 patients History of left arm claudication, 
dizziness & vertigo.
Severe stenosis of the left SA in 33 patients & of the right SA in 6 patients. With 
bilateral severe ICA stenosis in 2 patients
18 patients History of arm claudication, 
Dizziness, vertigo.
Severe stenosis of the left SA in 12 & of the right SA in 3 patients. Contralateral 
ICA stenosis in 3 pts
SA = subclavian artery; ICA = internal carotid artery
GROUP B
FIGURE 2. Subclavian angioplasty and stenting in a 55-year-old 
symptomatic patient (Catheterization & Interventional Lab, 
General Hospital of Nikaea, Piraeus).
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trauma to the neck.
The subclavian steal syndrome refers to a combination 
of neurological symptoms. These symptoms are due to ver-
tebrobasilar insufficiency because of the steal phenomenon, 
originating from the subclavian artery stenosis proximal 
to vertebral artery’s origin. Endovascular management of 
supra-aortic atherosclerotic vascular disease is becoming 
relatively common in the innominate and subclavian arter-
ies. Angioplasty can be proposed to the majority of patients 
presenting with significant subclavian symptomatic stenosis. 
The percutaneous procedure is less invasive than surgery 
and periprocedural complications rates are fewer than those 
of surgery.
Our experience comes from the endovascular treatment 
of 129 subclavian arteries in symptomatic patients. It is a 
relatively easy procedure and complications are rare. Imme-
diately after the procedure the symptoms disappear and the 
steal syndrome is reversed. Balloon catheter dilation of the 
proximal subclavian stenosis in symptomatic patients is the 
treatment of choice, as judged by our own experience and the 
data in the literature.
Endovascular treatment of vertebrobasilar insufficiency is 
not routinely performed in peripheral interventional programs. 
Randomized data comparing medical therapy, endovascular 
treatment, or surgical treatment do not exist. Our experience 
comes from the treatment of 52 symptomatic patients with 
severe >70% vertebral artery stenosis. There was primary 
technical success in all cases. Cardiological stents were placed 
in all of these patients. Balloon predilation of the vertebral 
stenosis was performed in 7 patients followed by stent place-
ment. Follow up (3-36 months) showed two cases of restenosis 
and all the other patients remain asymptomatic.
We believe angioplasty alone or combined with stenting is 
the treatment of choice for vertebral artery revascularization 
due to the high technical success rate, the low incidence of 
morbidity and mortality, and long-term durability.5 The avail-
able literature demonstrates that angioplasty with stent place-
ment of posterior circulation, in symptomatic, vertebrobasilar 
atherosclerotic disease, is a safe and effective approach that 
avoids the morbidity associated with major surgery.6 Diagnos-
tic angiography of both the posterior and anterior cerebral 
circulations is required before performing angioplasty. Special 
attention must be paid to collateral supply from the contral-
ateral vertebral artery, as well as the external carotid artery, 
from which collaterals may restitute the distal vertebral artery 
in cases of vertebral occlusion or severe stenosis. Also, patients 
may have excellent filling of the posterior circulation via the 
posterior communicating arteries and may tolerate stenosis of 
one or both vertebral arteries. Considering these possibilities 
for collateral blood flow, it is not surprising that lesions in the 
vertebrobasilar system are often asymptomatic and that only 
a minority of patients will benefit from treatment.7
C O N C L U S I O N
The immediate and up to 36 months follow-up results 
of PTA appear satisfactory. There is also the advantage of 
a less invasive procedure since surgery has a limited success 
and excessive morbidity. We believe that we have to treat 
symptomatic patients with vertebral artery flow-obstructing 
stenosis that causes brain stem ischemia, and in whom medical 
treatment failed to resolve the symptoms especially those with 
concomitant contralateral vertebral severe stenosis >70% or 
with hypoplastic artery. We conclude also from our results 
by measuring the rS02 with cerebral oximetry that we have to 
treat tight vertebral stenosis with left or right severe carotid 
artery stenosis in order to increase blood flow to the basilar 
artery. We must also treat symptomatic tight subclavian artery 
stenosis, or candidates for “bypass” surgery, with balloon ex-
pandable stents, to avoid the subclavian steal syndrome from 
the anterior discending coronary artery through the internal 
mammary graft.
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